2021 annual financial data
Viking Therapeutics 2021 Net margin
Viking Therapeutics 2021 net margin with verified reported values.
Direct answer
Net margin was -513,877.21%.
Operating income was -55,682,000 USD and net income was -54,990,000 USD.
Operating cash flow was -47,586,000 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,701 USD
- Operating income
- -55,682,000 USD
- Net income
- -54,990,000 USD
- Operating cash flow
- -47,586,000 USD